Àü³²´ëº´¿ø ±â½ÂÁ¤¡¤ÃÖÇö¿ì ±³¼öÆÀ ±¹Á¦Çмú´ëȸ¼­ ¡®¿ì¼öÇмú»ó¡¯ ¼ö»ó
¿Àº¹ ±âÀÚ
2023³â 08¿ù 16ÀÏ(¼ö) 20:20
±â½ÂÁ¤(ñ§), ÃÖÇö¿ì
Àü³²´ëº´¿ø ±³¼öÆÀÀÌ ¼¼°è ÃÖ´ë ±Ô¸ð Áø´Ü°Ë»ç ºÐ¾ß Çмú´ëȸ¿¡¼­ ¼ö»óÇϸç À§»óÀ» ³ô¿´´Ù.

16ÀÏ Àü³²´ëÇб³º´¿ø¿¡ µû¸£¸é Áø´Ü°Ë»çÀÇÇаú ±â½ÂÁ¤¡¤ÃÖÇö¿ì ±³¼öÆÀÀÌ Áö³­´Þ 23ÀϺÎÅÍ 5ÀÏ°£ ¹Ì±¹ ¾Ö³ÊÇÏÀÓ¿¡¼­ ¿­¸° ¡®2023 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting¡¯¿¡¼­ ÀÓ»óÁø´Ü¸é¿ªºÐ°ú ¿ì¼öÇмú»ó(Abstract Award in Clinical and Diagnostic Immunology)À» ¼ö»óÇß´Ù.

¿ÃÇØ·Î 74ȸ¸¦ ¸ÂÀº AACC Çмú´ëȸ´Â ¹Ì±¹ÀÓ»óÈ­ÇÐȸ°¡ ÁÖ°üÇÏ´Â Àü ¼¼°è Áø´Ü°Ë»çÀÇÇÐ Àü¹®ÀÇ¿Í °ü·Ã¾÷ü °ü°èÀÚµéÀÌ Âü¿©ÇÏ´Â ¼¼°è ÃÖ´ë ±Ô¸ðÀÇ Áø´Ü°Ë»ç ºÐ¾ß Çмú´ëȸÀÌÀÚ ¹Ú¶÷ȸ´Ù.

À̹ø Çмú´ëȸ¿¡´Â ÃÑ 780¿©°ÇÀÇ ³í¹®ÃÊ·ÏÀÌ Á¦ÃâµÆÀ¸¸ç ÀÓ»óÁø´Ü¸é¿ªºÐ°ú·Î Á¦ÃâµÈ 140¿©°Ç Áß 3°ÇÀÌ ¿ì¼öÇмú»óÀ¸·Î ¼±Á¤, ¿¬±¸³»¿ëÀ» ¹ßÇ¥Çß´Ù.

±â½ÂÁ¤¡¤ÃÖÇö¿ì ±³¼öÆÀÀÌ ¹ßÇ¥ÇÑ ¿¬±¸´Â ¡®Ç× DFS-70 Ç×ü °ËÃâÀ» µ¿¹ÝÇÑ AC-2 ÆÐÅÏ º¸°íÀÇ ÀÓ»óÀû À¯¿ë¼º(The Clinical Utility of Reporting AC-2 Pattern With Anti-DFS70 Antibody)¡¯À¸·Î ÀÚ°¡¸é¿ªÁúȯÀÇ ¼±º°°Ë»ç·Î ½ÃÇàµÇ´Â Ç×ÇÙÇ×ü(antinuclear antibody¡¤ANA), °£Á¢¸é¿ªÇü±¤Ç×ü°Ë»ç¹ý(indirect immunofluorescence assay¡¤IFA)¿¡¼­ °üÂûµÇ´Â dense fine speckled(DFS) ÆÐÅÏ°ú °ü·Ã Ç×üÀÎ anti-DFS70 Ç×ü¿¡ ´ëÇÑ ÀÓ»óÀû À¯¿ë¼ºÀ» ºÐ¼®ÇÑ º¸°í´Ù./¿Àº¹ ±âÀÚ
¿Àº¹ ±âÀÚ
ÀÌ ±â»ç´Â ±¤ÁÖ¸ÅÀϽŹ® ȨÆäÀÌÁö(kjdaily.com)¿¡¼­ ÇÁ¸°Æ® µÇ¾ú½À´Ï´Ù.

URL : http://www.kjdaily.com/1692184810609110062
ÇÁ¸°Æ® ½Ã°£ : 2024³â 10¿ù 05ÀÏ 21:23:51